Breaking News

BioAsia 2020 Announces the Genome Valley Excellence Award to Dr. Carl H June & Dr. Vas Narasimhan

·         The Award are going to be presented to Dr. June for the event of revolutionary T-Cell Therapy for Cancer Treatment; CAR-T Therapy led to a paradigm shift in cancer treatment along side the potential to treat more diseases within the near future.

· Dr. Vas Narasimhan, CEO of worldwide drug company - Novartis are going to be conferred for his extensive work on public health issues in developing countries and galvanizing the planet with the bold new vision to reimagine the pharmaceutical business including embracing digital technology and reworking healthcare.

BioAsia, Asia's largest annual global Biotechnology and Life Sciences forum organized by the govt of Telangana, has announced that the distinguished Genome Valley Excellence Award are going to be bestowed upon Dr. Carl H June, CAR-T Cell Therapy Pioneer, Richard W. Vague Professor in Immunotherapy, Dept. of Pathology and Laboratory Medicine, University of Pennsylvania, USA for his pioneering add the sector of immunotherapy; breakthrough research in developing CAR-T therapy for treatment of Cancer and development and commercialization of world’s first FDA-approved gene therapy and Dr. Vas (Vasant) Narasimhan, CEO of Novartis for uplifting the planet with the bold new vision to reimagine the pharmaceutical business including embracing digital technology and reworking healthcare; his extensive work on a variety of public health issues particularly in developing countries and exemplary add development of over 20 novel medicines, including advances cell and gene therapies also as vaccines. The award are going to be presented to them during the 17th edition of BioAsia which can be held between February 17 to 19, 2020 at HICC, Hyderabad.

Dr. Carl H June is an American immunologist and Oncologist. he's the pioneer within the field of immunotherapy and globally acknowledged for the event of T-Cell Therapy for Cancer. His findings have helped to develop and commercialize the primary FDA approved gene therapy called Tisagenlecleucel. CAR-T Cell therapy, a sort of immunotherapy that uses specially altered T-Cells (a a part of the immune system) to fight cancer. A sample of patient’s T-Cells is collected from the blood then modified to supply special structures called Chimeric Antigen Receptors (CARs) on their surface. Dr. June is Richard W. Vague Professor in Immunotherapy, Dept. of Pathology and Laboratory Medicine, University of Pennsylvania, USA.

Dr. Vasant Narasimhan, popularly referred to as Vas Narasimhan, is that the CEO of a worldwide drug company – Novartis. he's an Indian American Physician and has led a strategic and cultural transformation at Novartis to create a number one medicines company globally powered by advanced therapy platforms and data science. Dr. Narasimhan joined Novartis in 2005 and he served because the Global Head of Development before he assumed charge of CEO of the corporate in 2017. Dr. Narasimhan previously served as Global Head of Biopharmaceuticals and Oncology injectables at Sandoz International. he's a member of the US National Academy of drugs together with his ancestral roots at Tamil Nadu , Dr. Narasimhan completed his graduation in biological sciences from University of Chicago and did his MD from Harvard school of medicine . He also completed his master’s degree publicly Policy from John F Kennedy School of state , US.

Genome Valley Excellence Award was constituted in 2004 to acknowledge and honour eminent individuals and organizations for his or her exceptional contribution to the Life Sciences research and public health. the govt of Telangana presents this special award to eminent leaders per annum after a careful examination and technical consideration by the reputed jury committee appointed by it.

Speaking on 2020 Genome Valley Excellence Award, Mr Jayesh Ranjan, Principal Secretary, Dept of Industries & Commerce, Govt. of Telangana, said, "We are pleased to announce the distinguished Genome Valley Excellence Award 2020 to Dr. Carl H June and Dr. Vas Narasimhan for his or her remarkable contributions to the life sciences sector which might further revolutionize the entire public health across the world . BioAsia, attracts lot of the simplest minds of the life sciences industry across the planet and is a superb platform for industry, academia, scientific community and startups to interact, network and build relationships towards the core objectives of their respective fields. the govt of Telangana has always been supportive of innovations in Life Sciences and is committed to helping the industry to grow by providing it the world-class infrastructure while ensuring time-bound approvals to enhance the convenience of doing business within the state".

Elaborating the importance of Genome Valley Excellence Award, Mr. Shakthi Nagappan, CEO, BioAsia & Director (Life Sciences and Pharma), Government of Telangana, said, "Presenting the Genome Valley Excellence Award is one among the highlights of the BioAsia summit organized per annum we've been conferring the prominent scientists, industry leaders and organizations who are inspiring the leaders to hitch the mission of improving human life and made significant contributions to the Life Sciences sector across the world . Over the years, the Genome Valley Excellence Award has been gaining tremendous esteem among the worldwide lifesciences community as several Nobel laureates also are among the recipients of this prestigious award".

BioAsia 2020 is about to host eminent global industry leaders from the life sciences sector including Dr. Vas Narasimhan, CEO, Novartis, Dr. Carl June, CAR-T Expert, University of Pennsylvania, Dr. Peter Piot, Director, London School of Hygiene and medicine , and Co-Discoverer of Ebola, Mr. Ajay Piramal, Chairman, Piramal Group, Mr. Dilip Shanghvi, Chairman, Sun Pharma, Mrs. Kiran Mazumdar Shaw, CMD, Biocon, Mr. K Satish Reddy, Chairman, Dr. Reddy’s Laboratories, among others.

No comments